The formation of Fe3+-doxycycline complex is pH dependent: implications to doxycycline bioavailability. 2023

Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
Life Sciences Department, University of Belgrade-Institute for Multidisciplinary Research, Kneza Višeslava 1, 11000, Belgrade, Serbia. jskorac@gmail.com.

The interactions of drugs with iron are of interest in relation to the potential effects of iron-rich foods and iron supplements on sorption and bioavailability. Doxycycline (DOX), a member of the tetracycline class of broad-spectrum antibiotics, is frequently administered by oral route. In the digestive tract, DOX can be exposed to iron at different pH values (stomach pH 1.5-4, duodenum pH 5-6, distal jejunum and ileum pH 7-8). In relation to this, we analyzed the impact of pH on Fe3+-DOX complex formation. The optimal conditions for Fe3+-DOX complex formation are pH = 4 and [Fe3+]/[DOX] = 6 molar ratio. HESI-MS showed that Fe3+-DOX complex has 1:1 stoichiometry. Raman spectra of Fe3+-DOX complex indicate the presence of two Fe3+-binding sites in DOX structure: tricarbonylamide group of ring A and phenolic-diketone oxygens of BCD rings. The Fe3+-DOX complex formed at pH = 4 is less susceptible to oxidation than DOX at this pH. The increase of pH induces the decomposition of Fe3+-DOX complex without oxidative degradation of DOX. The pH dependence of Fe3+-DOX complex formation may promote unwanted effects of DOX, impeding the absorption that mainly takes place in duodenum. This could further result in higher concentrations in the digestive tract and to pronounced impact on gut microbiota.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D004318 Doxycycline A synthetic tetracycline derivative with similar antimicrobial activity. 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-,Alpha-6-Deoxyoxytetracycline,Atridox,BMY-28689,BU-3839T,Doryx,Doxycycline Calcium,Doxycycline Calcium Salt (1:2),Doxycycline Hemiethanolate,Doxycycline Hyclate,Doxycycline Monohydrate,Doxycycline Monohydrochloride, 6-epimer,Doxycycline Monohydrochloride, Dihydrate,Doxycycline Phosphate (1:1),Doxycycline-Chinoin,Hydramycin,Oracea,Periostat,Vibra-Tabs,Vibramycin,Vibramycin Novum,Vibravenos,Alpha 6 Deoxyoxytetracycline,BMY 28689,BMY28689,BU 3839T,BU3839T,Doxycycline Chinoin,Doxycycline Monohydrochloride, 6 epimer,Vibra Tabs
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
September 1997, The Journal of rheumatology,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
September 1990, Arzneimittel-Forschung,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
January 2014, RSC advances,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
October 1974, Current therapeutic research, clinical and experimental,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
November 2005, Journal of the American Chemical Society,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
May 2016, Environmental toxicology and chemistry,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
February 2019, Global challenges (Hoboken, NJ),
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
February 2022, Inorganica chimica acta,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
November 1995, Talanta,
Jelena Korać Jačić, and Milena Dimitrijević, and Danica Bajuk-Bogdanović, and Dalibor Stanković, and Slađana Savić, and Ivan Spasojević, and Milica R Milenković
October 1987, European journal of biochemistry,
Copied contents to your clipboard!